MENON, Bijoy K., Fahad S. AL-AJLAN, Mohamed NAJM, Josep PUIG, Mar CASTELLANOS, Dar DOWLATSHAHI, Ana CALLEJA, Sung Il SOHN, Seong H. AHN, Alex POPPE, Robert MIKULÍK, Negar ASDAGHI, Thalia S. FIELD, Albert JIN, Talip ASIL, Jean Martin BOULANGER, Eric E. SMITH, Shelag B. COUTTS, Phil A. BARBER, Simerpreet BAL, Suresh SUBRAMANIAN, Sachin MISHRA, Anurag TRIVEDI, Sadanand DEY, Muneer EESA, Tolulope SAJOBI, Mayank GOYAL, Michael D. HILL a Andrew M. DEMCHUK. Association of Clinical, Imaging, and Thrombus Characteristics With Recanalization of Visible Intracranial Occlusion in Patients With Acute Ischemic Stroke. JAMA-Journal of the American Medical Association. Chicago, USA: American Medical Association, 2018, roč. 320, č. 10, s. 1017-1026. ISSN 0098-7484. Dostupné z: https://dx.doi.org/10.1001/jama.2018.12498.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Association of Clinical, Imaging, and Thrombus Characteristics With Recanalization of Visible Intracranial Occlusion in Patients With Acute Ischemic Stroke
Autoři MENON, Bijoy K. (124 Kanada), Fahad S. AL-AJLAN (682 Saúdská Arábie), Mohamed NAJM (724 Španělsko), Josep PUIG (724 Španělsko), Mar CASTELLANOS (724 Španělsko), Dar DOWLATSHAHI (124 Kanada), Ana CALLEJA (724 Španělsko), Sung Il SOHN (410 Korejská republika), Seong H. AHN (410 Korejská republika), Alex POPPE (124 Kanada), Robert MIKULÍK (203 Česká republika, domácí), Negar ASDAGHI (840 Spojené státy), Thalia S. FIELD (124 Kanada), Albert JIN (124 Kanada), Talip ASIL (792 Turecko), Jean Martin BOULANGER (124 Kanada), Eric E. SMITH (124 Kanada), Shelag B. COUTTS (124 Kanada), Phil A. BARBER (124 Kanada), Simerpreet BAL (124 Kanada), Suresh SUBRAMANIAN (124 Kanada), Sachin MISHRA (36 Austrálie), Anurag TRIVEDI (124 Kanada), Sadanand DEY (124 Kanada), Muneer EESA (124 Kanada), Tolulope SAJOBI (124 Kanada), Mayank GOYAL (124 Kanada), Michael D. HILL (124 Kanada) a Andrew M. DEMCHUK (124 Kanada, garant).
Vydání JAMA-Journal of the American Medical Association, Chicago, USA, American Medical Association, 2018, 0098-7484.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30210 Clinical neurology
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 51.273
Kód RIV RIV/00216224:14110/18:00105510
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1001/jama.2018.12498
UT WoS 000444341400015
Klíčová slova anglicky Acute Ischemic Stroke
Štítky 14110127, rivok
Změnil Změnila: Soňa Böhmová, učo 232884. Změněno: 9. 2. 2019 20:44.
Anotace
IMPORTANCE Recanalization of intracranial thrombus is associated with improved clinical outcome in patients with acute ischemic stroke. The association of intravenous alteplase treatment and thrombus characteristics with recanalization over time is important for stroke triage and future trial design. OBJECTIVE To examine recanalization over time across a range of intracranial thrombus occlusion sites and clinical and imaging characteristics in patients with ischemic stroke treated with intravenous alteplase or not treated with alteplase. DESIGN, SETTING, AND PARTICIPANTS Multicenter prospective cohort study of 575 patients from 12 centers (in Canada, Spain, South Korea, the Czech Republic, and Turkey) with acute ischemic stroke and intracranial arterial occlusion demonstrated on computed tomographic angiography (CTA). EXPOSURES Demographics, clinical characteristics, time from alteplase to recanalization, and intracranial thrombus characteristics (location and permeability) defined on CTA. MAIN OUTCOMES AND MEASURES Recanalization on repeat CTA or on first angiographic acquisition of affected intracranial circulation obtained within 6 hours of baseline CTA, defined using the revised arterial occlusion scale (rAOL) (scores from 0 [primary occlusive lesion remains the same] to 3 [complete revascularization of primary occlusion]). RESULTS Among 575 patients (median age, 72 years [IQR, 63-80]; 51.5% men; median time from patient last known well to baseline CTA of 114 minutes [IQR, 74-180]), 275 patients (47.8%) received intravenous alteplase only, 195 (33.9%) received intravenous alteplase plus endovascular thrombectomy, 48 (8.3%) received endovascular thrombectomy alone, and 57 (9.9%) received conservative treatment. Median time from baseline CTA to recanalization assessment was 158 minutes (IQR, 79-268); median time from intravenous alteplase start to recanalization assessment was 132.5 minutes (IQR, 62-238). Successful recanalization occurred at an unadjusted rate of 27.3%(157/575) overall, including in 30.4%(143/470) of patients who received intravenous alteplase and 13.3%(14/105) who did not (difference, 17.1%[95% CI, 10.2%-25.8%]). Among patients receiving alteplase, the following factors were associated with recanalization: time from treatment start to recanalization assessment (OR, 1.28 for every 30-minute increase in time [95% CI, 1.18-1.38]), more distal thrombus location, eg, distal M1 middle cerebral artery (39/84 [46.4%]) vs internal carotid artery (10/92 [10.9%]) (OR, 5.61 [95% CI, 2.38-13.26]), and higher residual flow (thrombus permeability) grade, eg, hairline streak (30/45 [66.7%]) vs none (91/377 [24.1%]) (OR, 7.03 [95% CI, 3.32-14.87]). CONCLUSIONS AND RELEVANCE In patients with acute ischemic stroke, more distal thrombus location, greater thrombus permeability, and longer time to recanalization assessment were associated with recanalization of arterial occlusion after administration of intravenous alteplase; among patients who did not receive alteplase, rates of arterial recanalization were low. These findings may help inform treatment and triage decisions in patients with acute ischemic stroke.
VytisknoutZobrazeno: 18. 7. 2024 00:35